Yang Liu
Shenyang Pharmaceutical University(CN)Fujian University of Traditional Chinese Medicine(CN)Sun Yat-sen University(CN)Nanyang Technological University(SG)Guizhou University(CN)Xiamen University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Liaoning University of Traditional Chinese Medicine(CN)Chinese PLA General Hospital(CN)Soochow University(CN)Affiliated Hospital of Southwest Medical University(CN)Hetao College(CN)First Affiliated Hospital of Jiangxi Medical College(CN)Beijing Biocytogen (China)(CN)Environmental Protection Engineering (Greece)(GR)Affiliated Hospital of Guizhou Medical University(CN)Second Hospital of Tianjin Medical University(CN)Drug Discovery Laboratory (Norway)(NO)Office of the Governor(US)China Academy of Chinese Medical Sciences(CN)First Affiliated Hospital of Soochow University(CN)Inner Mongolia Autonomous Region Hospital of Traditional Chinese Medicine(CN)University of Chinese Academy of Sciences(CN)State Key Laboratory of Oncology in South ChinaTianjin Medical University(CN)Southern Medical University(CN)Nanjing Medical University(CN)
Publications by Year
Research Areas
Natural product bioactivities and synthesis, HIV Research and Treatment, Peptidase Inhibition and Analysis, HIV/AIDS drug development and treatment, Chemical Synthesis and Reactions
Most-Cited Works
- → Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy(2008)528 cited
- → Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection(2005)349 cited
- → Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies(2013)181 cited
- → Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B(2005)180 cited
- → Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP(2021)175 cited
- → Hypoxia-inducible factors in cancer stem cells and inflammation(2015)119 cited